Sponsor:
Chugai Pharmaceutical
Code:
NCT06371417
Conditions
Antiphospholipid Syndrome (APS)
Bullous Pemphigoid (BP)
Behçet's Syndrome (BS)
Dermatomyositis (DM)
Immune-mediated Necrotizing Myopathy (IMNM)
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
RAY121
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-09-23. This information was provided to ClinicalTrials.gov by Chugai Pharmaceutical on 2025-05-20.